drugset / Trial / NCT02596360

Dextromethorphan Effect on Central Sensitization to Pain in Healthy Volunteers

NCT02596360

Phase 1 Completed 20 enrolled University Hospital, Clermont-Ferrand
RandomizedCrossoverDouble-blindTreatment

Summary

The aim of this study is to assess the anti-hyperalgesic effect of dextromethorphan in healthy volunteers compared to placebo.

Timeline

Start
2015-11
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextromethorphan Unknown 30 mg

Indications

No indication recorded.